Welcome to Drug and Alcohol Treatment
| ||
Thousand Oaks Drug Alcohol Treatment Article
This is a selection made from among articles on Thousand Oaks Drug Alcohol Treatment. For a permanent link to this article, or to bookmark it for future reading, click here.
Residential Drug Treatment Centers
from:by Kerry Emrich
Chemical dependency recovery provides with positive changes in reactions and behaviors. Residential Treatment Centers can be accommodate those suffering from alcoholism, drug addiction, gambling addiction, and more. Treating both men and women together, or separately, they can offer the assistance that you need . Some residential treatment centers can even provide an atmosphere for specific cultural groups.Recovery from any addiction requires changes in reactions and behaviors. A residential drug treatment center may be on of the best choices you can make if you are looking towards getting the experiences to help yourself overcome any stumbling blocks along the way so you can not only recover but learn how you can feel more relaxed.The staff of the drug treatment centers are astounding at handling your needs. You will find, depending on what residential drug treatment center you choose, programs supervised by doctors, nurses, and highly trained professionals. Many centers employ professional dieticians and chefs to meet your nutritional needs. These people work together to help you relax and get the most out of the treatment program.A residential drug treatment center provides a safe environment in which the addict is provided with quality counseling, help, and friendship. Residential treatment centers provide an escape from the streets, negative consequences, and bad environments which speeds the recovery from drug and alcohol addiction. Many recovery facilities offer private rooms, home cooked meals, smoking and non-smoking areas, and meditation and weight training.Education and training, guidance and help are the foundation of residential drug treatment centers. They provide the skills necessary to recover and enjoy a healthy mind, body, and spirit. Any setbacks can be overcome with the proper support.Recovery is only the commencement of a astounding new life! The addict learns to be free from the bonds of alcohol and drugs and experiences healing, self expression, and joy. This not only benefits the individual, but their family and friends as well. This new found freedom will last a lifetime.Personalized treatment and help is the goal of most residential drug treatment centers. 12 Step Programs such as Alcoholics Anonimous (AA), Narcotics Anonymous (NA), Cocaine Anonymous (CA), and Gamblers Anonymous (GA) are often integrated into the residential drug treatment center programs. Aftercare is another benefit of most drug and alcoholic treatment centers. Treatment groups and individual treatment play a major role in the process of recovering from addictions. Group sessions are anonymous so you can relax and talk about your feelings with others suffering from similar problems. Alcoholism, gambling addiction, and drug addiction problems can often be overcome faster with care from others facing the same hurdles. Residential treatment program doctors or councilors, specializing in addiction disorders and treating chemical dependency disorders, can offer help and advice.Every year, thousands of sufferers successfully recover from their addictions. Treatment programs offer the tools and aid needed to overcome addiction and live from from addiction. They can enjoy a new world free from problems.
The author is a health care writer with a background in psychology, NLP, and addictions. For more information on this and other subjects visit us at: Residential Drug Treatment Center
Thousand Oaks Drug Alcohol Treatment Specific links
Thousand Oaks Drug Alcohol Treatment News
FDA Skeptical of Amgen Drug Ahead of Panel - TheStreet.com
 USA TODAY | FDA Skeptical of Amgen Drug Ahead of Panel TheStreet.com By Adam Feuerstein 02/06/12 - 09:13 AM EST THOUSAND OAKS, Calif. (TheStreet) -- Amgen's(AMGN) effort to expand the use of new drug Xgeva to prevent or delay the spread of prostate cancer to the bones of patients is being met with skepticism by US ... Amgen to Discuss Application for New Use of XGEVA® (denosumab) at FDA ... Amgen Fails to Win Advisory Panel Backing for Expanded Use of Cancer Drug FDA questions Amgen drug for prostate cancer |
Amgen to buy drug developer Micromet for $1.16 billion - Los Angeles Times
 Los Angeles Times | Amgen to buy drug developer Micromet for $1.16 billion Los Angeles Times The acquisition will help Thousand Oaks biotech giant Amgen broaden its product pipeline with Micromet's drug being tested as a treatment for leukemia and non-Hodgkin's lymphoma. Fresh off mixed earnings, Amgen said it will shell out $1.16 billion to ... Amgen To Buy Peer Micromet For $1.16 Bln |
California company buys Rockville biopharmaceutical firm for $1.16 billion - Washington Post
 Los Angeles Times | California company buys Rockville biopharmaceutical firm for $1.16 billion Washington Post Rockville-based Micromet, a biopharmaceutical firm that creates antibody-based cancer treatments, agreed to be bought Thursday for $1.16 billion by Amgen, a biotechnology company in Thousand Oaks, Calif. The sale price equates to $11 per share, ... Amgen 4Q Profit Falls 9% On Tax Impacts, Charges Amgen 4Q Profit Down 9 Pct., But Sales Up 3 Pct Amgen Misses Profit Estimates on Slowing Anemia Drug Sales |
Constipation drug offers more potential for Bethesda's Sucampo - Gazette.Net: Maryland Community News Online
Constipation drug offers more potential for Bethesda's Sucampo Gazette.Net: Maryland Community News Online Amgen, of Thousand Oaks, Calif., was established in 1980. It develops treatments for cancer, kidney disease, rheumatoid arthritis, bone disease and other illnesses. Among its more well-known products is Enbrel, for treating psoriatic arthritis. |
Actelion 'Make or Break' Lung Treatment Seen Having 63% Chance of Success - Bloomberg
 Bloomberg | Actelion 'Make or Break' Lung Treatment Seen Having 63% Chance of Success Bloomberg Actelion will probably announce the results of a decisive trial of the lung treatment, macitentan, in the second quarter, Clozel said this month. Among 12 analysts asked by Bloomberg News to predict the likelihood the drug will meet the main goal of ... |
Nothing says 'I love you' like a kidney - Ventura County Star
Nothing says 'I love you' like a kidney Ventura County Star The Thousand Oaks couple will mark 45 years of marriage this April. "I'm so proud of her," Alex said, tears flooding his eyes. "I'm sorry I had to take it (the kidney)." Alex blinked, looked away, then strode into the kitchen. "You want some coffee? |
Can Vermont Fix Its "Dysfunctional" System of Treating Opiate Addicts? - Seven Days
 Seven Days | Can Vermont Fix Its "Dysfunctional" System of Treating Opiate Addicts? Seven Days But for hundreds, perhaps thousands, of Vermont addicts who are hooked on heroin or prescription painkillers, the hardest part is finding someone to treat their dependency. Opiate abuse in the Green Mountain State has reached epidemic proportions in ... |
Facebook Alternatives: Less Hype, More Hope - Wall Street Journal
Facebook Alternatives: Less Hype, More Hope Wall Street Journal The 16-year-old company, based in Thousand Oaks, Calif., had $7 million in sales in the last year. Also expected to make its debut will be ChemoCentryx, based in Mountain View, Calif. The company is developing drugs to combat Crohn's disease and ... |
Earnings Preview: Amgen to report 4Q results - CBS News
Earnings Preview: Amgen to report 4Q results CBS News Bradway will become the fourth CEO of the Thousand Oaks, Calif.-based company when Kevin Sharer steps down in May. The maker of Neulasta, for reducing infections in chemotherapy patients, has had just one blockbuster medicine approved in the last ... |
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly - Xconomy
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly Xconomy Now the Palo Alto, CA-based company (NASDAQ: AFFY) is making all sorts of moves behind the scenes that will determine how big a bite it will take out of Thousand Oaks, CA-based Amgen's multi-billion dollar anemia drug monopoly. |